New research published in INQUIRY: The Journal of Health Care Organization, Provision, and Financing suggests that the rapid expansion of Medicare Advantage (MA) enrollment over the past decade has contributed to a significant reduction in overall Medicare spending. The study, conducted by the Elevance Health Public Policy Institute, indicates that as more beneficiaries transition from traditional fee-for-service (FFS) Medicare to private managed care plans, the resulting "spillover effect" influences provider behavior and lowers per capita costs across the entire program. By analyzing county-level data from 2012 to 2021, researchers concluded that the growth of Medicare Advantage saved the federal government an estimated $111 billion during that period compared to a baseline where enrollment remained at 2011 levels.
The findings come at a critical juncture for the Medicare program, which is facing mounting fiscal pressure and intense regulatory scrutiny. As of 2024, Medicare Advantage enrollment has reached 32 million people, representing 54% of the total Medicare population. This marks a dramatic shift from 2010, when only 11 million beneficiaries, or roughly 25% of the total, were enrolled in private plans. The Elevance Health study argues that this shift has created an environment where healthcare providers increasingly adopt efficient clinical practices that benefit all patients, regardless of whether they are in a managed care or fee-for-service arrangement.
Methodology and Key Data Points
The Elevance Health study utilized comprehensive data from the Centers for Medicare & Medicaid Services (CMS), focusing on county-level spending and enrollment figures for Medicare Advantage, fee-for-service Medicare, and Part D prescription drug coverage. The researchers aimed to quantify the relationship between "MA penetration"—the percentage of Medicare beneficiaries in a specific area enrolled in private plans—and the total cost of care.
According to the report, a 10-percentage-point increase in Medicare Advantage penetration is associated with a 1.5% decrease in total Medicare spending per capita, which translates to a saving of approximately $194 per beneficiary. Recognizing the ongoing debate regarding "coding intensity"—the practice where MA plans may document more diagnoses to increase reimbursement—the researchers also provided an adjusted figure. After accounting for the Medicare Payment Advisory Commission’s (MedPAC) estimates of higher coding intensity, the study still found a 1.1% reduction in total spending, or $146 per capita.
The cumulative financial impact is substantial. The $111 billion in estimated savings between 2012 and 2021 represents a significant offset to the program’s long-term liabilities. Even with the conservative coding intensity adjustment, the estimated savings remain high at $83 billion.
The Chronology of Medicare Advantage Growth
To understand the context of these findings, it is necessary to examine the evolution of the Medicare Advantage program. Originally established as "Medicare+Choice" under the Balanced Budget Act of 1997, the program was rebranded as Medicare Advantage with the passage of the Medicare Modernization Act of 2003.
For the first decade of the 2000s, growth was steady but relatively modest. However, the 2010s saw an acceleration in adoption, driven by several factors:
- Expanded Benefit Packages: MA plans began offering supplemental benefits not covered by traditional Medicare, such as dental, vision, hearing, and fitness memberships.
- Financial Predictability: Unlike traditional Medicare, which often requires separate Medigap policies to cover out-of-pocket costs, MA plans feature an annual limit on out-of-pocket expenditures.
- Focus on Care Coordination: The transition toward value-based care incentivized plans to focus on chronic disease management, reducing the need for expensive hospital readmissions.
By 2021, the final year of the Elevance study, MA penetration had crossed the 40% threshold in many states. By 2024, the program surpassed the majority mark, with more than half of all eligible seniors choosing private plans over the traditional government-run option.
Understanding the "Spillover Effect"
One of the most significant takeaways from the Elevance research is the explanation for why MA growth lowers costs even for those who remain in traditional Medicare. This phenomenon, often referred to as the "spillover effect," occurs when the practice patterns established for managed care patients influence how doctors treat their entire patient panel.
The report notes that as Medicare Advantage enrollment increases, providers often align their behavior with the quality and efficiency incentives inherent in MA plans. These incentives prioritize:
- Chronic Condition Management: Proactive monitoring of patients with diabetes, hypertension, or heart disease to prevent acute episodes.
- Reduced Utilization of High-Cost Services: Avoiding unnecessary advanced imaging (such as MRIs or CT scans) and opting for more cost-effective diagnostic paths.
- Site-of-Service Optimization: Shifting care from expensive hospital settings to ambulatory surgical centers or home-based care when appropriate.
Because physicians typically do not maintain two entirely different clinical workflows for MA and FFS patients, the efficiencies gained through MA contracts tend to "spill over" into the fee-for-service sector, thereby lowering the total per capita spending for the region.
Conflicting Perspectives: The MedPAC Report
While the Elevance Health study paints a positive picture of MA’s fiscal impact, it stands in contrast to recent reports from MedPAC, an independent congressional agency. In its January 2024 report, MedPAC estimated that Medicare Advantage payments in 2026 would be $76 billion higher than what the government would have spent if those same beneficiaries were enrolled in traditional fee-for-service Medicare.
MedPAC’s criticism centers on the "benchmark" system used to pay private plans. Critics argue that the current payment formula, combined with "quality bonuses" and the aforementioned coding intensity, results in the government paying a premium for MA enrollees. The MedPAC analysis suggests that while MA may be more efficient at the clinical level, the federal government is not capturing those savings; instead, they are being redirected into extra benefits for enrollees or profit margins for insurers.
The Elevance study challenges this narrative by looking at "total" spending rather than just "per-enrollee" payments. By including the downward pressure MA puts on FFS costs, the researchers argue that the program’s net effect on the Treasury is more nuanced than MedPAC’s figures suggest.
Industry Reactions and Policy Implications
Jennifer Kowalski, Vice President of the Elevance Health Public Policy Institute, emphasized that the study highlights the inextricable link between the two halves of the Medicare program. In an interview following the release of the report, Kowalski noted that it is no longer possible to assess traditional Medicare in a vacuum.
"It’s clear that Medicare Advantage plays an important role in the overall Medicare program," Kowalski stated. "I don’t think you can say here’s what fee-for-service would look like absent MA, because there is such an influence of MA. I think what this says is we really need to think about how we make the program sustainable and efficient and available to beneficiaries moving forward."
The healthcare industry at large is currently navigating a period of significant regulatory adjustment. For 2025, CMS has implemented a series of rate updates and changes to the risk adjustment model (known as V28), which aims to curb overpayments and more accurately reflect the health status of enrollees. These changes have been met with resistance from major insurers, who argue that reduced funding could lead to higher premiums or reduced benefits for seniors.
Fact-Based Analysis of Future Implications
The findings of the Elevance study suggest that any policy decisions aimed at "leveling the playing field" between MA and FFS must account for the indirect benefits MA provides. If the spillover effect is as potent as the research indicates, a significant contraction in the Medicare Advantage market could inadvertently lead to a spike in per capita spending within the traditional fee-for-service program.
Furthermore, the study highlights a geographic disparity in Medicare efficiency. Counties with high MA penetration appear to have more modernized healthcare delivery systems. This suggests that federal policy might focus on encouraging MA growth in rural or underserved areas where penetration remains low, potentially unlocking further systemic savings.
However, the tension between the Elevance findings and the MedPAC reports ensures that Medicare Advantage will remain a focal point of political debate. With the Medicare Hospital Insurance (Part A) Trust Fund projected to face insolvency in the mid-2030s, the pressure to optimize every dollar spent is higher than ever.
Conclusion
The Elevance Health Public Policy Institute’s research provides a data-driven argument for the broader economic value of Medicare Advantage. By documenting $111 billion in savings and a clear correlation between plan penetration and lower per capita costs, the study adds a layer of complexity to the ongoing discussion regarding Medicare’s future. As the program continues to evolve, the challenge for policymakers will be to balance the documented clinical efficiencies of private managed care with the need for fiscal transparency and payment accuracy at the federal level. For now, the "spillover effect" remains a compelling piece of evidence that the influence of Medicare Advantage extends far beyond its 32 million direct enrollees.
